Page last updated: 2024-08-24
plerixafor and wp1066
plerixafor has been researched along with wp1066 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jin, YB; Jung, JE; Jung, MJ; Kim, YM; Ko, YG; Lee, JC; Lee, JS; Lee, SJ; Park, MJ; Rho, JK | 1 |
Other Studies
1 other study(ies) available for plerixafor and wp1066
| Article | Year |
|---|---|
Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
Topics: Animals; Benzylamines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Drug Resistance, Neoplasm; Female; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Receptors, CXCR4; RNA Interference; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; TOR Serine-Threonine Kinases; Tyrphostins; Up-Regulation | 2013 |